Navigation Links
Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up

cluding corticosteroids, immunosuppressants or 5ASAs, were enrolled in ACT 1 (n=364) or ACT 2 (n=364). The 728 patients were randomized to receive REMICADE 5 mg/kg, REMICADE 10 mg/kg or placebo at weeks 0, 2, 6 and every subsequent 8 weeks through week 22 (ACT 2) or week 46 (ACT 1). Patients were allowed to continue to receive conventional therapy.

Patients who had benefited from treatment with REMICADE and, in the investigators opinion, could enroll in the extension trials; 118 patients entered the ACT 1 extension and 111 patients entered the ACT 2 extension. During the extension, patients continued to receive REMICADE 5 mg/kg or REMICADE 10 mg/kg every 8 weeks. Patients in the extension trials were assessed using the PGA, which is 1 of 4 measures of disease activity included in the Mayo score. Of these 229 patients who entered the extension, 181 have been followed through one year, and 92 have completed two years. Patients who had responded to placebo also enrolled in the extension to maintain the blind and continued to receive placebo every 8 weeks, but were discontinued upon unblinding.

Over the course of the extension trials subjects were allowed to adjust corticosteroid use as required. When corticosteroid use during the extension in all participants (which included subjects previously on corticosteroids and those that had not used corticosteroids) was examined, a smaller proportion of the subjects who had completed follow-up through Weeks 56 and 104 were using corticosteroids. At weeks 8, 56 and 104 of the ACT extension trials, 80 percent, 88 percent and 98 percent of patients, respectively, were corticosteroid-free.

Overall, side effects were generally well tolerated with less than five percent of patients discontinuing therapy due to an adverse event (AE). As previously reported, other notable serious adverse events (SAEs) included: prostate cancer, breast cancer, pneumonia, sarcoidosis, abscess and a death following Histoplasmosis pneu
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
4. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
5. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
6. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
7. UCB Presents Long-Term CImzia Data in Crohns Disease
8. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
11. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
Post Your Comments:
(Date:5/20/2013)... Ill. , May 20, 2013 Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... announced today that its Board of Directors declared, at ... cash dividend of $0.55 per share for the third ... on July 3, 2013, to shareholders of record on ...
(Date:5/20/2013)... May 20, 2013  Valeant Pharmaceuticals International, Inc. (NYSE: ... senior management team will make a presentation at the 34 ... 11, 2013 at 9:20 a.m. PT. The conference will be ... CA. A live webcast and audio ... Web site at www.valeant.com . Click on Investor Relations, ...
(Date:5/20/2013)... VIEW, Calif. , May 20, 2013 /PRNewswire-iReach/ ... results of the first study demonstrating detection of ... Yersinia pestis and Bacillus anthracis ... Control and Prevention,s list of potential bio-threats. This ... Science and Technology Laboratory, Salisbury ...
Breaking Medicine Technology:Landauer, Inc. Declares Regular Cash Dividend 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Administration (FDA) has accepted for review the Company,s Biologics ... of the neovascular form of age-related macular degeneration (wet ... priority review of its BLA.  A Priority Review designation ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
(Date:5/21/2013)... 21, 2013 The birth control safety ... who have used the contraceptive NuvaRing. A new report ... clot injuries has increased in recent months*. , DrugRisk ... and devices with the latest safety alerts, recalls, studies ... are experiencing similar side effects and decide if they ...
(Date:5/20/2013)... 2013 USA Book News announced Monday ... Peak Performance" won the top honor in its 2013 ... over a multitude of international titles published from 2011-2013, ... acclaim from both mainstream and new age audiences looking ... and spiritually. , “The Infinity Zone” is ...
(Date:5/20/2013)... Texas (PRWEB) May 21, 2013 ... on product type into two categories - semi-automated ... market is classified into five categories, namely, hospitals, ... market is forecast till 2017. Automated external defibrillators ... of sudden cardiac arrest victims. Considering the life-saving ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Florida (PRWEB) May 20, 2013 In order ... supplemental health and wellness team from DrSmartphoneMD launched an article ... serious sunburns. , The series launched with the ... that members of the DrSmartphoneMD program are not one of ... team explained that more than 90% of all skin cancer ...
Breaking Medicine News(10 mins):Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2
... showed a positive response in both metastatic breast cancer ... Clinical Cancer Research , a journal of the ... we can clearly generate immune responses that lead to ... Gulley, M.D., Ph.D., director and deputy chief of the ...
... (CBR) is elevated in the livers of fish that have ... Gothenburg can show that CBR has properties that may make ... warning signal of environmental toxins. The aim of the project ... the levels of environmental toxins, we biologists monitor their effects. ...
... Nov. 8 (HealthDay News) -- The reversal of a kidney ... new organ from a deceased donor, U.S. researchers say. ... priority to potential recipients who had a genetic match with ... in the body,s immune response to foreign tissue. HLA-B similarity ...
... 17 months, researchers with the National Space Biomedical Research ... prolonged operational confinement on the sleep, performance, and mood ... in Moscow. The 520-day simulation, which concluded Nov. 4, ... Russian Federation Institute for Biomedical Problems (IBMP) of ...
... at UC Santa Barbara have provided a new twist ... both nature and nurture, in introducing a framework for ... how genotypes (nature) can express themselves differently as a ... current issue of the journal Social Psychological and ...
... diabetes, including kidney disease, foot problems and vision problems ... the brain is often overlooked. For the past ... Medical Center (BIDMC) neurophysiologist Vera Novak, MD, PhD, has ... in older individuals and has determined that memory loss, ...
Cached Medicine News:Health News:An enzyme in fish can demonstrate environmental toxins 2Health News:Racial Disparities Still Exist for Kidney Recipients, Study Finds 2Health News:US institute wraps up data collection in Russian Mars 520-day mission simulation 2Health News:US institute wraps up data collection in Russian Mars 520-day mission simulation 3Health News:UCSB psychology professors study gene-culture interaction 2Health News:UCSB psychology professors study gene-culture interaction 3Health News:Researchers identify diabetes link to cognitive impairment in older adults 2Health News:Researchers identify diabetes link to cognitive impairment in older adults 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: